References
- Anastyuk SD, Barabanova AO, Correc G, Nazarenko EL, Davydova VN, Helbert W, Dmitrenok PS, Yermak IM. 2011. Analysis of structural heterogeneity of κ/β-carrageenan oligosaccharides from Tichocarpus crinitus by negative-ion ESI and tandem MALDI mass spectrometry. Carbohydr Polym. 86:546–554.
- Beattie IA, Blakemore WR, Dewar ET, Warwick MH. 1970. A study of orally-administered degraded carrageenan in the baboon. Food Cosmet Toxicol. 8:257–266.
- Blakemore WR, Davis SR, Hroncich MM, Vurma M. 2014. Carrageenan analysis: part 1: stability in swine-adapted infant formula. Food Addit Contam; Part A. doi:10.1080/19440049.2014.955536
- Blakemore WR, Kwok SK, Harding NI. 2014. Carrageenan analysis: part 2: quantification in swine-adapted infant formula. Food Addit Contam; Part A. doi:10.1080/19440049.2014.955537
- Brant AF. 2013. Interim final report: full validation of an LC-MS/MS assay for poligeenan in minipig plasma with K2 EDTA. MPI Study Number 167–172 (FMC Study Number I2013-7864). Mattawan (MI): MPI Research Inc.
- Ekeberg D, Knutsen SH, Sletmoen M. 2001. Negative-ion electrospray ionisation – mass spectrometry (ESI-MS) as a tool for analysing structural heterogeneity in Kappa-Carrageenan Oligosaccharides. Carbohydr Res. 334:49–59.
- Grebe SKG, Singh RJ. 2011. Review article, LC-MS/MS in the clinical laboratory – where to from here? Clin Biochem Rev. 32:5–31.
- McKim J. 2014. Food additive carrageenan: part I: a critical review of carrageenan in vitro studies, potential pitfalls, and implications for human health and safety. Crit Rev Toxicol. 44:211–243.
- [USAN] United States Adopted Names Council. 1988. List number 297 new names, Poligeenan. Clin Pharmacol Ther. 44:246–248.
- Weiner ML. 2014. Food additive carrageenan: part II: a critical review of carrageenan in vivo safety studies. Crit Rev Toxicol. 44:244–269.